Option Care Health Inc

Option Care Health Inc (OPCH) Stock Analysis

$23.900

-0.079 (-0.33%)At close

Loading chart…
High
24.160
Open
24.000
VWAP
23.98
Vol
1.20M
Mkt Cap
4.86B
Low
23.870
Amount
28.67M
EV/EBITDA, TTM
10.77

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

AI analysis of Option Care Health Inc (OPCH)

hold

Option Care Health Inc is currently not a strong buy. The stock is priced at $23.90, which is below the recent analyst price target of $24, indicating limited upside potential. Additionally, the forward P/E ratio of 12.85 suggests it is relatively undervalued, but the recent downgrades and a year-to-date decline of 25.87% raise concerns about future performance.

Valuation Metrics

The current forward P/E ratio for Option Care Health Inc (OPCH) is 12.85, compared to its 5-year average forward P/E of 25.37.

Forward P/E

Undervalued
5Y Average P/E
25.37
Current P/E
12.85
Overvalued
31.96
Undervalued
18.77

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
14.31
Current EV/EBITDA
10.77
Overvalued
17.47
Undervalued
11.15

Forward P/S

Undervalued
5Y Average P/S
1.07
Current P/S
0.59
Overvalued
1.33
Undervalued
0.82

Alphio AI Price Scenarios for OPCH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%OPCH

$38.45

Scenario price

B

Base

Base · 50%OPCH

$31.36

Scenario price

B

Bear

Bear · 25%OPCH

$30.06

Scenario price

Whales holding OPCH

S

Southpoint Capital Advisors LP

+ HoldingOPCH

+11.41%

3M Return

D

Durable Capital Partners, LP

+ HoldingOPCH

+1.98%

3M Return

S

Staley Capital Advisers, Inc.

+ HoldingOPCH

+1.21%

3M Return

OPCH FAQ — answered by Alphio AI

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Option Care Health Inc is currently not a strong buy. The stock is priced at $23.90, which is below the recent analyst price target of $24, indicating limited upside potential. Additionally, the forward P/E ratio of 12.85 suggests it is relatively undervalued, but the recent downgrades and a year-to-date decline of 25.87% raise concerns about future performance.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始